TP53 and ovarian carcinoma: A recent study provided evidence that miR-214 affects the ovarian cancer stem cell properties by targeting p53/NANOG axis: in fact, enforcing expression of miR-214 increases, while miR-214 knockdown decreases, the size and self-renewal of ovarian cancer stem cells [304].